| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;110:672-0679
© 1995 Mosby, Inc.
SURGERY FOR ACQUIRED HEART DISEASE |
Ghent and Brussels, Belgium
Received for publication August 12, 1994. Accepted for publication Dec. 29, 1994. Address for reprints: Guido J. Van Nooten, MD, Cardiac Surgery Department, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.
Abstract
A series of 146 consecutive patients who underwent tricuspid valve replacement at the University Brugmann Hospital between 1967 and 1987 was reviewed. Mean age at operation was 51.4 years (±12.1 years). Different types of prostheses were implanted including porcine and bovine pericardial bioprostheses and older and bileaflet mechanical valves. Most patients were severely disabled by their cardiac disease before operation, with 30.1% in New York Heart Association functional class III and 69.9% in class IV. Operative mortality and hospital mortality rates (30 days) were high (16.4%). Incremental risk factors for hospital death included icterus (p<0.005), preoperative hepatomegaly (p= 0.012), and New York Heart Association functional class IV (p= 0.013). Multivariate analysis only selected preoperative icterus (p<0.01) as being independently significantly related to hospital mortality. The hospital survivors were followed up for a median of 94 months. A complete follow-up was available for all patients except two for 30 months or more. At 30 months the only two significant parameters were the type of myocardial protection (p= 0.024) and the year of operation (before 1977 or after [precardioplegia era or after], p= 0.011). There were 70 late deaths during the entire follow-up period. The univariate (log-rank statistics) incremental risk factor for late death was the type of tricuspid prosthesis (Smeloff-Cutter and Kay-Shiley versus St. Jude Medical versus bioprosthesis) (p= 0.04). A trend was observed for the type of operative myocardial protection (normothermia and coronary perfusion) (p= 0.06) and preoperative New York Heart Association functional class IV (p= 0.055). Actuarial survival was 74% at 60 months and 23.4% at 180 months. Cumulative follow-up added up to 1015 patient-years. In a more detailed analysis of the effect on survival of the type of tricuspid prosthesis, a significant difference was observed between the bioprostheses and some older mechanical prostheses (Smeloff-Cutter and Kay-Shiley) (p= 0.04) but not between the bioprostheses and the bileaflet valves (p= 0.15). When the follow-up period was stratified according to less than 7 years and more than 7 years of follow-up, no difference was observed for the first period, but for the late follow-up the new mechanical prostheses did better than the bioprostheses (p= 0.05), suggesting a degradation of the bioprostheses after 7 years and favoring mechanical prostheses for those patients with a good long-term prognosis. (J THORACCARDIOVASCSURG1995;110:672-9)
This article has been cited by other articles:
|
|
 |
|
  S. Tokunaga, M. Masuda, A. Shiose, Y. Tomita, S. Morita, and R. Tominaga Long-Term Results of Isolated Tricuspid Valve Replacement Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 25 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1111 - 1128. [Full Text]
|
|
|
|
|
|
H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text]
|
|
|
|
 |
|
 R. Gottardi, J. Bialy, E. Devyatko, H. Tschernich, M. Czerny, E. Wolner, and R. Seitelberger Midterm Follow-Up of Tricuspid Valve Reconstruction Due to Active Infective Endocarditis Ann. Thorac. Surg., December 1, 2007; 84(6): 1943 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kunadian, K. Vijayalakshmi, S. Balasubramanian, and J. Dunning Should the tricuspid valve be replaced with a mechanical or biological valve? Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 551 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Anagnostopoulos, N. Alphonso, L. Nolke, L. K. Hornberger, G. W. Raff, A. Azakie, and T. R. Karl Neonatal Mitral and Tricuspid Valve Repair for In Utero Papillary Muscle Rupture Ann. Thorac. Surg., April 1, 2007; 83(4): 1458 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Bartlett, D. L. Atkins, T. L. Burns, K. J. Engelkes, S. J. Powell, C. B. Hills, and J. H. Moller Early Outcomes of Tricuspid Valve Replacement in Young Children Circulation, January 23, 2007; 115(3): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Singh, G. H.L. Tang, M. D. Maganti, S. Armstrong, W. G. Williams, T. E. David, and M. A. Borger Midterm Outcomes of Tricuspid Valve Repair Versus Replacement for Organic Tricuspid Disease Ann. Thorac. Surg., November 1, 2006; 82(5): 1735 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Q. Lai, X. Meng, T. Bai, C. Zhang, Y. Luo, and Z.-G. Zhang Edge-to-Edge Tricuspid Valve Repair: An Adjuvant Technique for Residual Tricuspid Regurgitation Ann. Thorac. Surg., June 1, 2006; 81(6): 2179 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho Long-Term Clinical Results of Tricuspid Valve Replacement Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Filsoufi, A. C. Anyanwu, S. P. Salzberg, T. Frankel, L. H. Cohn, and D. H. Adams Long-Term Outcomes of Tricuspid Valve Replacement in the Current Era Ann. Thorac. Surg., September 1, 2005; 80(3): 845 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Kang, H. Ahn, K. H. Kim, and K.-B. Kim Long-Term Result of 1144 CarboMedics Mechanical Valve Implantations Ann. Thorac. Surg., June 1, 2005; 79(6): 1939 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakayama, M. Nonaka, and O. Ishida Reoperation of the Kay-Shiley Disc Valve 35 Years After Replacement Ann. Thorac. Surg., April 1, 2005; 79(4): 1395 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. T. A. De Smet, C. Stefanidis, M. Antoine, and G. Primo Long-term durability of three mechanical valves Ann. Thorac. Surg., July 1, 2004; 78(1): 384 - 384. [Full Text] [PDF]
|
|
|
|
|
|
N. A G Solomon, R. C H Lim, P. Nand, and K. J Graham Tricuspid Valve Replacement: Bioprosthetic or Mechanical Valve? Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rizzoli, I. Vendramin, G. Nesseris, T. Bottio, C. Guglielmi, and L. Schiavon Biological or mechanical prostheses in tricuspid position? a meta-analysis of intra-institutional results Ann. Thorac. Surg., May 1, 2004; 77(5): 1607 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Chachques, P. G. Argyriadis, G. Fontaine, J.-L. Hebert, R. A. Frank, N. D'Attellis, J.-N.o. Fabiani, and A. F. Carpentier Right ventricular cardiomyoplasty: 10-year follow-up Ann. Thorac. Surg., May 1, 2003; 75(5): 1464 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1001 - 1015. [Full Text]
|
|
|
|
|
|
H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358. [Full Text]
|
|
|
|
|
|
M. Kaplan, M. S. Kut, M. M. Demirtas, S. Cimen, and A. Ozler Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical Ann. Thorac. Surg., February 1, 2002; 73(2): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Puig, C. M. de Almeida Brandao, P. M. A. Pomerantzeff, F. A. Gaiotto, and S. A. de Oliveira Tricuspid dura mater bioprostheses: more than 20-year follow-up of 3 patients Ann. Thorac. Surg., August 1, 2001; 72(2): 615 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Mangoni, T. G. DiSalvo, G. J. Vlahakes, C. A. Polanczyk, and M. A. Fifer Outcome following isolated tricuspid valve replacement Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 68 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohata, I. Kigawa, Y. Yamashita, and Y. Wanibuchi Surgical strategy for severe tricuspid valve regurgitation complicated by advanced mitral valve disease: Long-term outcome of tricuspid valve supra-annular implantation in eighty-eight cases J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 280 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Bajzer, W. J. Stewart, D. M. Cosgrove, S. J. Azzam, K. L. Arheart, and A. L. Klein Tricuspid valve surgery and intraoperative echocardiography: Factors affecting survival, clinical outcome, and echocardiographic success J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1023 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Reddy, D. B. McElhinney, M. M. Brook, N. H. Silverman, P. Stanger, and F. L. Hanley Repair of congenital tricuspid valve abnormalities with artificial chordae tendineae Ann. Thorac. Surg., July 1, 1998; 66(1): 172 - 176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
